Hannah Seitz

CBO

Hannah joins LabGenius from drug discovery and development company Evotec, where she served as VP Global Business Development for Oncology, Immunology and Inflammation. In this role, she led the global out-licensing efforts across internal R&D assets and technology platforms, playing a pivotal part in securing a multi-year collaboration and license agreement with Pfizer. Prior to Evotec, Hannah spent over a decade as Director of Business Development at Daiichi Sankyo, focusing on in-licensing for oncology and rare diseases. During this time, she contributed to numerous early- and late-stage licensing agreements and M&A activities.